Skip to main content
. 2024 Jan 29;28(2):165–169. doi: 10.5005/jp-journals-10071-24635

Table 3.

Comparison between those with and without EVLW

  EVLW(+) (n = 54) EVLW(–) (n = 96) p-value
GCS on day 1* 7 (3–10) 8 (4–11) 0.324
APACHE II at admission* 23 (16–26) 19 (12–26) 0.044
APACHE II at 48 hours* 18 (9.25–25.75) 10.5 (4.75–19) 0.0005
SOFA score on day 1* 7 (5–11) 6 (3–10) 0.045
Albumin (gm/dL) on day 1* 2.8 (2.125–3.5) 3.1 (2.275–3.8) 0.29
Need for RRT# 11 (20.37%) 1 (1.04%) < 0.0001
Serum NT Pro BNP (ng/mL) levels on day 1* 3636 (1274–11638.5) 278 (50–2825.25) < 0.0001
PaO2/FiO2 ratio <300 on day 1** 40 (74.07%) 40 (41.67%) 0.0001
Sepsis** 40 (74.07%) 54 (56.25%) 0.03
Vasopressor** 31 (57.41%) 41 (42.71%) 0.084
High PEEP (≥10)# 6 (11.11%) 1 (1.04%) 0.009
Diuretics** 45 (83.33%) 23 (23.96%) <0.0001
Cumulative fluid balance (mL) over 1 week* –118.96 (–432.396–229.958) 546.67 (320.417–831.125) <0.0001
Weaning failure** 19 (35.19%) 15 (15.63%) 0.006
Duration of weaning (days)* 2 (2–3) 1 (1–2) <0.0001
Duration of mechanical ventilation (days)* 3.5 (3–5) 2 (2–3) <0.0001
Duration of ICU stay (days)* 5 (4–7) 4 (3–5) <0.0001
Mortality** 19 (35.19%) 15 (15.63%) 0.006

*Mann–Whitney test; Data represented as Median [IQR-Inter quartile range]; #Fisher's exact test; **Chi-square test. p-value (< 0.05 is significant)